Antioxidant, N-acetyl-L-cysteine inhibits the expression of the collagen α2 (I) promoter in the activated human hepatic stellate cell line in the absence as well as the presence of transforming growth factor-β

被引:12
作者
Segawa, M [1 ]
Kayano, K [1 ]
Sakaguchi, E [1 ]
Okamoto, M [1 ]
Sakaida, I [1 ]
Okita, K [1 ]
机构
[1] Yamaguchi Univ, Sch Med, Dept Gastroenterol & Hepatol, Yamaguchi 7558505, Japan
关键词
liver fibrosis; hepatic stellate cell; N-acetyl-L-cysteine; LI90; COL1A2; promoter;
D O I
10.1016/S1386-6346(02)00089-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Although recent studies suggest the inhibitory property of N-acetyl-L-cysteine (NAC) on activation of hepatic stellate cell (HSC), the effects on once-activated HSCs are not well clarified. We investigated the influences of NAC on human-derived once-activated HSC line, LI90 with a focus on the collagen alpha2 (I) (COL1A2) promoter expression. Plasmid containing whole length of COL1A2 promoter linked to firefly luciferase gene and its various 5'-deletions were transiently transfected to LI90. The luciferase activity was determined with or without 10 mM of NAC in the absence or presence of 1 ng/ml of transforming growth factor (TGF)-beta. The effects of NAC on generation of intracellular reactive oxygen species (ROS) in LI90 were also analyzed. As a result, NAC significantly (P < 0.05) suppressed the COL1A2 promoter expression in the absence or presence of TGF-beta. The expression was much more inhibited when used the deletion containing only AP-1/NF-kappaB binding sites than that including only three SP-1 binding sites. The ROS production was also comparably inhibited by NAC in both condition. These results indicated NAC suppressed, through its anti-oxidative action, the COL1A2 promoter expression in once-activated HSCs in the absence or presence of TGF-beta at least partly by affecting the signal transduction cascade encompassing AP-1/NF-kappaB activation. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:305 / 315
页数:11
相关论文
共 37 条
[1]
Baroni GS, 1996, HEPATOLOGY, V23, P1189
[2]
BASS DA, 1983, J IMMUNOL, V130, P1910
[3]
BEDOSSA P, 1994, HEPATOLOGY, V19, P1262, DOI 10.1016/0270-9139(94)90876-1
[4]
Hepatic fibrosis as wound repair: A progress report [J].
Bissell, DM .
JOURNAL OF GASTROENTEROLOGY, 1998, 33 (02) :295-302
[5]
BOAST S, 1990, J BIOL CHEM, V265, P13351
[6]
ACETALDEHYDE INCREASES PROCOLLAGEN TYPE-I AND FIBRONECTIN GENE-TRANSCRIPTION IN CULTURED RAT FAT-STORING CELLS THROUGH A PROTEIN-SYNTHESIS DEPENDENT MECHANISM [J].
CASINI, A ;
CUNNINGHAM, M ;
ROJKIND, M ;
LIEBER, CS .
HEPATOLOGY, 1991, 13 (04) :758-765
[7]
An AP-1 binding sequence is essential for regulation of the human alpha 2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta [J].
Chung, KY ;
Agarwal, A ;
Uitto, J ;
Mauviel, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) :3272-3278
[8]
RETINOIC ACID MODULATES RAT ITO CELL-PROLIFERATION, COLLAGEN, AND TRANSFORMING GROWTH-FACTOR-BETA PRODUCTION [J].
DAVIS, BH ;
KRAMER, RT ;
DAVIDSON, NO .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (06) :2062-2070
[9]
Fox ES, 1997, J IMMUNOL, V158, P5418
[10]
Cellular networks in hepatic fibrosis [J].
Friedman, SL .
DIGESTION, 1998, 59 (04) :368-371